Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
Employers Cut Off Access to Weight-Loss Drugs for Workers
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
Ozempic, Wegovy and Mounjaro Spark a Weight-Loss and Diet Industry Identity Crisis
Weight-loss businesses, which long pushed calorie-counting and willpower, are grappling with the surging popularity of new drugs. Source link
